
Research and drug development professional with keen expertise in clinical trials management in Phase I-IV trials in both clinical/ translational research. Credited with experience in quality and risk management across several therapeutic areas. Specialized in global pharmaceutical regulatory requirements as well as GCP, cGMP, GLP regulations. Committed to assisting project teams in providing reliable and effective assessment of the risk-benefit profiles of pharmaceutical products to exceed sponsor expectations. As a quality and risk professional I am truly dedicated to preserving the integrity of clinical data
CORE COMPETENCIES: Audits, Corrective & preventative action implementation, Root-cause analysis, FDA/ EMA/ MHRA Regulatory requirements, GCP / cGMP / GLP Regulations